Antibody data
- Antibody Data
- Antigen structure
- References [6]
- Comments [0]
- Validations
- Western blot [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 19793-1-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#19793-1-AP, RRID:AB_10638922
- Product name
- CCT6A-Specific antibody
- Antibody type
- Polyclonal
- Description
- CCT6A-Specific antibody (Cat. #19793-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse and has been validated for the following applications: WB,ELISA.
- Reactivity
- Human, Mouse
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references CCT6A facilitates lung adenocarcinoma progression and glycolysis via STAT1/HK2 axis.
CCT6A is associated with CDC20, Enneking stage and prognosis in osteosarcoma, and its knockdown suppresses osteosarcoma cell viability and invasion.
Albumosomes formed by cytoplasmic pre-folding albumin maintain mitochondrial homeostasis and inhibit nonalcoholic fatty liver disease.
CCT2 is an aggrephagy receptor for clearance of solid protein aggregates.
Proteomics Profiling of Autologous Blood and Semen Exosomes from HIV-infected and Uninfected Individuals Reveals Compositional and Functional Variabilities.
Molecular chaperone CCT3 supports proper mitotic progression and cell proliferation in hepatocellular carcinoma cells.
Yu SK, Yu T, Wang YM, Sun A, Liu J, Lu KH
Journal of translational medicine 2024 May 15;22(1):460
Journal of translational medicine 2024 May 15;22(1):460
CCT6A is associated with CDC20, Enneking stage and prognosis in osteosarcoma, and its knockdown suppresses osteosarcoma cell viability and invasion.
Wang N, Chen Y, Wu J
Oncology letters 2023 May;25(5):201
Oncology letters 2023 May;25(5):201
Albumosomes formed by cytoplasmic pre-folding albumin maintain mitochondrial homeostasis and inhibit nonalcoholic fatty liver disease.
Ma B, Ju A, Zhang S, An Q, Xu S, Liu J, Yu L, Fu Y, Luo Y
Signal transduction and targeted therapy 2023 Jun 16;8(1):229
Signal transduction and targeted therapy 2023 Jun 16;8(1):229
CCT2 is an aggrephagy receptor for clearance of solid protein aggregates.
Ma X, Lu C, Chen Y, Li S, Ma N, Tao X, Li Y, Wang J, Zhou M, Yan YB, Li P, Heydari K, Deng H, Zhang M, Yi C, Ge L
Cell 2022 Apr 14;185(8):1325-1345.e22
Cell 2022 Apr 14;185(8):1325-1345.e22
Proteomics Profiling of Autologous Blood and Semen Exosomes from HIV-infected and Uninfected Individuals Reveals Compositional and Functional Variabilities.
Kaddour H, Lyu Y, Welch JL, Paromov V, Mandape SN, Sakhare SS, Pandhare J, Stapleton JT, Pratap S, Dash C, Okeoma CM
Molecular & cellular proteomics : MCP 2020 Jan;19(1):78-100
Molecular & cellular proteomics : MCP 2020 Jan;19(1):78-100
Molecular chaperone CCT3 supports proper mitotic progression and cell proliferation in hepatocellular carcinoma cells.
Zhang Y, Wang Y, Wei Y, Wu J, Zhang P, Shen S, Saiyin H, Wumaier R, Yang X, Wang C, Yu L
Cancer letters 2016 Mar 1;372(1):101-9
Cancer letters 2016 Mar 1;372(1):101-9
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The CCT6A-Specific antibody from Proteintech is a rabbit polyclonal antibody to a peptide of human CCT6A-Specific. This antibody recognizes human, mouse antigen. The CCT6A-Specific antibody has been validated for the following applications: ELISA, WB analysis.